Facilitated By

San Antonio Medical Foundation

News

  • Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio ... Immutep is a late-stage biotechnology company developing novel ...

  • Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San ...

    ... Signatera will be shared at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place December 9-12.

  • Syantra Inc. to Showcase Breakthrough Research on Immune Reprogramming in Breast ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place December 9–12 ... biotechnology company pioneering a platform to change the way cancer is ...

  • Immutep : to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio, Texas, from December 9-12, 2025. The Phase II study randomised female ...

  • Texas' rapidly expanding medical THC program names nine likely new providers

    ... San Antonio. “States with comparable medical cannabis populations, like ... Lonestar Compassionate Care Group LLC in North Texas; Lone Star Bioscience ...